Regional
Automation in transfusion medicine and the future ahead
Rahul Katharia
Amrita Institute of Medical Sciences & Research Centre, India
Swati Pabbi
Amrita Institute of Medical Sciences & Research Centre, India
Automation is transforming transfusion medicine from a largely manual specialty into a digitally connected, technology-driven discipline.
Beyond automating laboratory tasks, advances in robotics, artificial intelligence (AI), and data analytics now support the entire transfusion pathway from donor recruitment and blood collection to component processing, testing, inventory management, and patient transfusion. Driven by increasing demand, workforce shortages, and the need for safer, standardised care, automation has become central to modern blood services. The next frontier is the Smart Blood Centre, where AI and real-time data will not only automate workflows but also predict blood demand, optimise inventory, support clinical decision-making, and enhance patient safety across the vein-to-vein pathway.is the Smart Blood Centre, where AI and real-time data will not only automate workflows but also predict blood demand, optimize inventory, support clinical decision-making, and enhance patient safety across the vein-to-vein pathway.
Why automation matters
Every blood component is a unique biological product collected from voluntary donors, making transfusion medicine one of the most quality-sensitive areas of healthcare. Traditionally, the transfusion pathway has relied on numerous manual processes, each carrying the potential for variability and human error. As blood services face increasing demand, limited workforce, and rising quality expectations, automation has become essential. By standardizing workflows, improving traceability, and reducing repetitive manual tasks, automation enhances safety and efficiency while enabling transfusion professionals to focus on clinical expertise and patient care.
Automation across the vein-to-vein pathway
Automation now supports every stage of the transfusion pathway, beginning with donor recruitment. Digital donor management systems integrate online appointments, electronic health questionnaires, automated eligibility assessment, and mobile applications that improve donor convenience and engagement. AI-based tools are also being explored to predict donor return behaviour, personalize recruitment strategies, and optimise blood collection.
Whole blood processing has historically been labor intensive, requiring multiple manual centrifugation and separation steps. Automation has fundamentally changed this process. Systems such as the Reveos® Automated Blood Processing System simultaneously process multiple whole blood donations using standardized centrifugation, automated component separation, and integrated quality monitoring [Figure.1]. The advantages extend beyond improved productivity, enabling the production of highly standardized and reproducible blood components while improving workflow efficiency and traceability.
Laboratory automation has had perhaps the greatest impact on transfusion services. Automated immunohematology, serology, and nucleic acid testing platforms perform high-volume testing with greater accuracy, consistency, and shorter turnaround times. Integrated laboratory information systems further enhances sample tracking, electronic reporting, and quality assurance, reducing manual errors while allowing transfusion professionals to focus on complex clinical and diagnostic decisions.
Figure 1: Reveos® Automated Blood Processing System
Digital traceability: following every blood component
Digital traceability is one of automation's greatest achievements, enabling every blood component to be tracked from donor to recipient. While barcodes have long supported product identification, Radio Frequency Identification (RFID) provides faster, contactless tracking with real-time visibility of inventory, storage conditions, and product movement throughout the blood supply chain.
At our centre, RFID technology has been integrated from inventory management to bedside transfusion. Each blood component is electronically linked to the intended recipient, and handheld RFID readers verify both patient identity and the blood unit before transfusion. This additional electronic safety check strengthens traceability, improves documentation, streamlines inventory management, and helps prevent "wrong blood to wrong patient" events. As RFID continues to evolve with environmental sensors and connected hospital systems, it will provide even greater oversight of blood storage, transportation, and cold-chain compliance. [Figure 2 & 3]
Figure 2: RFID system for Inventory Management and Bedside Monitoring
Figure 3: Real Time Traceability and Inventory Management.
Artificial intelligence: from automation to intelligence
While automation performs predefined tasks, AI transforms data into actionable insights. Blood centres generate vast amounts of operational and clinical data, and AI is beginning to unlock its potential to improve decision-making across the transfusion pathway.
Emerging applications include forecasting blood demand, optimising inventory particularly for short shelf life components such as platelets and personalizing donor recruitment based on donation patterns and regional needs. AI can also assist clinicians by integrating laboratory results, transfusion history, and clinical guidelines to support evidence-based transfusion decisions and strengthen Patient Blood Management (PBM) programmes. In quality management, AI enables continuous monitoring of key performance indicators, helping identify trends and predict potential issues before they affect patient care. Although human expertise remains central, AI has the potential to make blood services more proactive, efficient, and resilient.
Robotics: expanding the reach of blood services
Robotics is extending automation beyond the laboratory through automated blood processing systems, robotic specimen handling, and autonomous guided vehicles (AGVs) that streamline workflows while maintaining quality and cold-chain integrity. Drone-based delivery of blood products has also improved access to remote and hard-to-reach areas in several countries, reducing transport times during emergencies.
Smart blood centres: connecting the transfusion ecosystem
Automation is transforming conventional blood centres into Smart Blood Centres, where laboratory instruments, information systems, and inventory management platforms operate as an integrated digital ecosystem. Real-time data from every step of the transfusion pathway provide continuous operational insights, enabling proactive inventory management, quality monitoring, and informed decision-making. Technologies such as digital twins may further support blood centres by simulating workflow and inventory scenarios before operational changes are implemented.
This digital transformation extends beyond the blood centre into clinical practice. Electronic crossmatching, computerised physician order entry, remote blood issue systems, and bedside blood tracking using barcode or RFID technology strengthen transfusion safety while improving workflow efficiency. Together, these innovations are creating a seamless, vein-to-vein network that enhances patient care through greater connectivity, traceability, and operational intelligence.
Looking ahead
Automation is paving the way for precision transfusion medicine, where genomic technologies, AI, and advanced analytics support more individualized transfusion strategies. Molecular blood group typing will improve rare donor identification and enable better-matched transfusions for patients requiring chronic transfusion support, helping reduce alloimmunization and improve clinical outcomes. Future Smart Blood Centres will also place greater emphasis on sustainability. Intelligent inventory management, optimized logistics, and connected digital systems can reduce waste, minimize blood component discard, and improve the environmental footprint of blood services.
Despite these advances, important challenges remain. High implementation costs, limited interoperability, cybersecurity, and the need to develop a digitally skilled workforce continue to influence adoption, particularly in resource-limited settings. Ensuring equitable access to these technologies will require collaboration between healthcare providers, industry, and policymakers.
Most importantly, automation will complement not replace the expertise of transfusion medicine professionals. Clinical judgment, donor care, complex immunohematology, and patient-centred decision-making remain inherently human responsibilities.
Conclusion
Automation is transforming transfusion medicine by improving safety, efficiency, traceability, and quality across the entire vein-to-vein pathway. More than replacing manual processes, it is enabling smarter, data-driven blood services that can anticipate challenges, optimize resources, and support better clinical decisions. However, technology is only as effective as the people who use it. Successful implementation depends on strong governance, continuous innovation, workforce development, and collaboration across the transfusion community. As blood centres evolve into intelligent, connected ecosystems, the future of transfusion medicine will be shaped not only by automation and AI, but by the expertise, judgment, and compassion of the professionals who ensure that every patient receives the right blood, at the right time, and with the highest standards of care.
